FOXM1 and neoplasm: CENPF serves as both an important prognostic biomarker and a key oncogenic driver in HCC; its role has been independently confirmed through both bioinformatics and experimental validation, and it can cooperate with FOXM1 to co-regulate downstream targets such as POLD1, thereby promoting hepatocarcinogenesis and tumor progression [36,63].